To see the effect of Madhu Mishrit Panchvalkala Kashaya Kavala and Madhu Mishrit Triphala Kashaya Kavala in specific diseases of oral cavity
Phase 2
- Conditions
- Health Condition 1: A00-B99- Certain infectious and parasitic diseasesHealth Condition 2: A00-B99- Certain infectious and parasitic diseases
- Registration Number
- CTRI/2022/05/042943
- Lead Sponsor
- Patanjali Ayurved College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above 5 years of age.
Patients willing to participate in the trial.
Patients with classical symptoms of Mukhapaka.
Patients yogya for Kavala.
Exclusion Criteria
Patients below 5 years of age.
Patients not willing for trial.
Patients that are Ayogya for Kavala.
Congenital anomalies of mouth (Cleft lip, Cleft palate, oronasal fistula).
Traumatic wound of mouth (Dentures, sharp edged tooth).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the antimicrobial effects of Panchvalkala and Triphala Kashaya in oral cavity infections?
How does Madhu Mishrit Panchvalkala Kavala compare to standard-of-care therapies like chlorhexidine for oral infectious diseases?
Which biomarkers correlate with treatment response in CTRI/2022/05/042943's phase II trial of Ayurvedic oral rinses?
What adverse effects are reported in phase II trials of Madhu Mishrit Triphala Kashaya for oral mucosal conditions?
Are there combination therapies involving Panchvalkala and Triphala Kashaya for managing A00-B99 oral infections?